Compliance and persistence of endocrine adjuvant breast cancer therapy
✍ Scribed by Uwe Güth; Mary Elizabeth Myrick; Nerbil Kilic; Serenella Eppenberger-Castori; Seraina Margaretha Schmid
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 200 KB
- Volume
- 131
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Combined modality trials in early breast cancer have been underway since the 1960s and results are available to indicate varying degrees of success in Stage I and 11. The trials have involved more than 29,000 women in 61 randomized trials. The recommendations can be summarized by stage, estrogen rec
About 180,000 American women will be diagnosed with early stage breast cancer during 1993. In many of these patients breast cancer is a systemic disease at diagnosis and thus not curable by local treatment alone. The development of optimal forms of systemic adjuvant therapy has been a major area of